Found: 6
Select item for more details and to access through your institution.
Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 1, p. 249, doi. 10.1093/ndt/gfac294
- By:
- Publication type:
- Article
Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.859419
- By:
- Publication type:
- Article
Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28578-0
- By:
- Publication type:
- Article
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1145652
- By:
- Publication type:
- Article
Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1136723
- By:
- Publication type:
- Article
Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France.
- Published in:
- Journal of Clinical Immunology, 2023, v. 43, n. 8, p. 1724, doi. 10.1007/s10875-023-01558-9
- By:
- Publication type:
- Article